nodes	percent_of_prediction	percent_of_DWPC	metapath
Solifenacin—CYP3A4—Budesonide—ulcerative colitis	0.131	0.257	CbGbCtD
Solifenacin—CYP3A4—Methylprednisolone—ulcerative colitis	0.0586	0.115	CbGbCtD
Solifenacin—CYP3A4—Nicotine—ulcerative colitis	0.0571	0.112	CbGbCtD
Solifenacin—CYP3A4—Cholecalciferol—ulcerative colitis	0.0512	0.1	CbGbCtD
Solifenacin—CYP3A4—Triamcinolone—ulcerative colitis	0.0444	0.0868	CbGbCtD
Solifenacin—CYP3A4—Betamethasone—ulcerative colitis	0.0381	0.0745	CbGbCtD
Solifenacin—CYP3A4—Prednisolone—ulcerative colitis	0.0376	0.0735	CbGbCtD
Solifenacin—CYP3A4—Hydrocortisone—ulcerative colitis	0.0357	0.0697	CbGbCtD
Solifenacin—CYP3A4—Prednisone—ulcerative colitis	0.0355	0.0694	CbGbCtD
Solifenacin—CYP3A4—Dexamethasone—ulcerative colitis	0.0222	0.0433	CbGbCtD
Solifenacin—Muscular weakness—Dexamethasone—ulcerative colitis	0.000979	0.00234	CcSEcCtD
Solifenacin—Muscular weakness—Betamethasone—ulcerative colitis	0.000979	0.00234	CcSEcCtD
Solifenacin—Palpitations—Mesalazine—ulcerative colitis	0.000973	0.00232	CcSEcCtD
Solifenacin—Dyspepsia—Budesonide—ulcerative colitis	0.000972	0.00232	CcSEcCtD
Solifenacin—Cough—Mesalazine—ulcerative colitis	0.00096	0.00229	CcSEcCtD
Solifenacin—Decreased appetite—Budesonide—ulcerative colitis	0.00096	0.00229	CcSEcCtD
Solifenacin—Skin disorder—Azathioprine—ulcerative colitis	0.000958	0.00229	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Budesonide—ulcerative colitis	0.000953	0.00228	CcSEcCtD
Solifenacin—Nausea—Nicotine—ulcerative colitis	0.000953	0.00227	CcSEcCtD
Solifenacin—Fatigue—Budesonide—ulcerative colitis	0.000952	0.00227	CcSEcCtD
Solifenacin—Hypertension—Mesalazine—ulcerative colitis	0.00095	0.00227	CcSEcCtD
Solifenacin—Constipation—Budesonide—ulcerative colitis	0.000944	0.00225	CcSEcCtD
Solifenacin—Infestation NOS—Methylprednisolone—ulcerative colitis	0.000941	0.00225	CcSEcCtD
Solifenacin—Infestation—Methylprednisolone—ulcerative colitis	0.000941	0.00225	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—ulcerative colitis	0.00093	0.00222	CcSEcCtD
Solifenacin—Dry mouth—Mesalazine—ulcerative colitis	0.000916	0.00219	CcSEcCtD
Solifenacin—Feeling abnormal—Budesonide—ulcerative colitis	0.00091	0.00217	CcSEcCtD
Solifenacin—Confusional state—Mesalazine—ulcerative colitis	0.000906	0.00216	CcSEcCtD
Solifenacin—Gastrointestinal pain—Budesonide—ulcerative colitis	0.000903	0.00216	CcSEcCtD
Solifenacin—Anaphylactic shock—Mesalazine—ulcerative colitis	0.000898	0.00214	CcSEcCtD
Solifenacin—Hallucination—Hydrocortisone—ulcerative colitis	0.000894	0.00214	CcSEcCtD
Solifenacin—Infection—Mesalazine—ulcerative colitis	0.000892	0.00213	CcSEcCtD
Solifenacin—Dry skin—Prednisone—ulcerative colitis	0.000886	0.00212	CcSEcCtD
Solifenacin—Connective tissue disorder—Hydrocortisone—ulcerative colitis	0.000883	0.00211	CcSEcCtD
Solifenacin—Nervous system disorder—Mesalazine—ulcerative colitis	0.000881	0.0021	CcSEcCtD
Solifenacin—Urticaria—Budesonide—ulcerative colitis	0.000877	0.00209	CcSEcCtD
Solifenacin—Tachycardia—Mesalazine—ulcerative colitis	0.000877	0.00209	CcSEcCtD
Solifenacin—Abdominal pain—Budesonide—ulcerative colitis	0.000873	0.00208	CcSEcCtD
Solifenacin—Skin disorder—Mesalazine—ulcerative colitis	0.000872	0.00208	CcSEcCtD
Solifenacin—Muscular weakness—Prednisone—ulcerative colitis	0.000853	0.00204	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.000851	0.00203	CcSEcCtD
Solifenacin—Hallucination—Methylprednisolone—ulcerative colitis	0.00084	0.00201	CcSEcCtD
Solifenacin—Pharyngitis—Triamcinolone—ulcerative colitis	0.00084	0.00201	CcSEcCtD
Solifenacin—Eye disorder—Hydrocortisone—ulcerative colitis	0.00084	0.00201	CcSEcCtD
Solifenacin—Connective tissue disorder—Methylprednisolone—ulcerative colitis	0.00083	0.00198	CcSEcCtD
Solifenacin—Hypersensitivity—Budesonide—ulcerative colitis	0.000814	0.00194	CcSEcCtD
Solifenacin—Feeling abnormal—Azathioprine—ulcerative colitis	0.000813	0.00194	CcSEcCtD
Solifenacin—Immune system disorder—Hydrocortisone—ulcerative colitis	0.000812	0.00194	CcSEcCtD
Solifenacin—Gastrointestinal pain—Azathioprine—ulcerative colitis	0.000806	0.00193	CcSEcCtD
Solifenacin—Somnolence—Mesalazine—ulcerative colitis	0.000798	0.00191	CcSEcCtD
Solifenacin—Asthenia—Budesonide—ulcerative colitis	0.000792	0.00189	CcSEcCtD
Solifenacin—Dyspepsia—Mesalazine—ulcerative colitis	0.000791	0.00189	CcSEcCtD
Solifenacin—Eye disorder—Methylprednisolone—ulcerative colitis	0.000789	0.00188	CcSEcCtD
Solifenacin—Mental disorder—Hydrocortisone—ulcerative colitis	0.000788	0.00188	CcSEcCtD
Solifenacin—Cardiac disorder—Methylprednisolone—ulcerative colitis	0.000784	0.00187	CcSEcCtD
Solifenacin—Malnutrition—Hydrocortisone—ulcerative colitis	0.000783	0.00187	CcSEcCtD
Solifenacin—Pruritus—Budesonide—ulcerative colitis	0.000781	0.00187	CcSEcCtD
Solifenacin—Decreased appetite—Mesalazine—ulcerative colitis	0.000781	0.00186	CcSEcCtD
Solifenacin—Abdominal pain—Azathioprine—ulcerative colitis	0.000779	0.00186	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.000775	0.00185	CcSEcCtD
Solifenacin—Fatigue—Mesalazine—ulcerative colitis	0.000774	0.00185	CcSEcCtD
Solifenacin—Constipation—Mesalazine—ulcerative colitis	0.000768	0.00183	CcSEcCtD
Solifenacin—Angiopathy—Methylprednisolone—ulcerative colitis	0.000766	0.00183	CcSEcCtD
Solifenacin—Hallucination—Dexamethasone—ulcerative colitis	0.000764	0.00182	CcSEcCtD
Solifenacin—Hallucination—Betamethasone—ulcerative colitis	0.000764	0.00182	CcSEcCtD
Solifenacin—Immune system disorder—Methylprednisolone—ulcerative colitis	0.000763	0.00182	CcSEcCtD
Solifenacin—Mediastinal disorder—Methylprednisolone—ulcerative colitis	0.000761	0.00182	CcSEcCtD
Solifenacin—Vision blurred—Prednisolone—ulcerative colitis	0.000755	0.0018	CcSEcCtD
Solifenacin—Depression—Prednisone—ulcerative colitis	0.000743	0.00177	CcSEcCtD
Solifenacin—Feeling abnormal—Mesalazine—ulcerative colitis	0.00074	0.00177	CcSEcCtD
Solifenacin—Mental disorder—Methylprednisolone—ulcerative colitis	0.00074	0.00177	CcSEcCtD
Solifenacin—Malnutrition—Methylprednisolone—ulcerative colitis	0.000735	0.00176	CcSEcCtD
Solifenacin—Gastrointestinal pain—Mesalazine—ulcerative colitis	0.000734	0.00175	CcSEcCtD
Solifenacin—Angioedema—Prednisolone—ulcerative colitis	0.000732	0.00175	CcSEcCtD
Solifenacin—Dizziness—Budesonide—ulcerative colitis	0.00073	0.00174	CcSEcCtD
Solifenacin—Hypersensitivity—Azathioprine—ulcerative colitis	0.000726	0.00173	CcSEcCtD
Solifenacin—Dysgeusia—Triamcinolone—ulcerative colitis	0.000722	0.00172	CcSEcCtD
Solifenacin—Eye disorder—Dexamethasone—ulcerative colitis	0.000718	0.00171	CcSEcCtD
Solifenacin—Eye disorder—Betamethasone—ulcerative colitis	0.000718	0.00171	CcSEcCtD
Solifenacin—Angioedema—Hydrocortisone—ulcerative colitis	0.000715	0.00171	CcSEcCtD
Solifenacin—Urticaria—Mesalazine—ulcerative colitis	0.000714	0.0017	CcSEcCtD
Solifenacin—Abdominal pain—Mesalazine—ulcerative colitis	0.00071	0.0017	CcSEcCtD
Solifenacin—Vomiting—Budesonide—ulcerative colitis	0.000702	0.00168	CcSEcCtD
Solifenacin—Angiopathy—Betamethasone—ulcerative colitis	0.000697	0.00166	CcSEcCtD
Solifenacin—Angiopathy—Dexamethasone—ulcerative colitis	0.000697	0.00166	CcSEcCtD
Solifenacin—Rash—Budesonide—ulcerative colitis	0.000696	0.00166	CcSEcCtD
Solifenacin—Dermatitis—Budesonide—ulcerative colitis	0.000696	0.00166	CcSEcCtD
Solifenacin—Headache—Budesonide—ulcerative colitis	0.000692	0.00165	CcSEcCtD
Solifenacin—Hypertension—Prednisolone—ulcerative colitis	0.000692	0.00165	CcSEcCtD
Solifenacin—Hypertension—Hydrocortisone—ulcerative colitis	0.000676	0.00161	CcSEcCtD
Solifenacin—Angioedema—Triamcinolone—ulcerative colitis	0.000673	0.00161	CcSEcCtD
Solifenacin—Angioedema—Methylprednisolone—ulcerative colitis	0.000672	0.0016	CcSEcCtD
Solifenacin—Hallucination—Prednisone—ulcerative colitis	0.000666	0.00159	CcSEcCtD
Solifenacin—Hypersensitivity—Mesalazine—ulcerative colitis	0.000662	0.00158	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000662	0.00158	CcSEcCtD
Solifenacin—Connective tissue disorder—Prednisone—ulcerative colitis	0.000657	0.00157	CcSEcCtD
Solifenacin—Nausea—Budesonide—ulcerative colitis	0.000656	0.00157	CcSEcCtD
Solifenacin—Anaphylactic shock—Prednisolone—ulcerative colitis	0.000654	0.00156	CcSEcCtD
Solifenacin—Dizziness—Azathioprine—ulcerative colitis	0.000652	0.00156	CcSEcCtD
Solifenacin—Asthenia—Mesalazine—ulcerative colitis	0.000644	0.00154	CcSEcCtD
Solifenacin—Cough—Triamcinolone—ulcerative colitis	0.000643	0.00154	CcSEcCtD
Solifenacin—Anaphylactic shock—Hydrocortisone—ulcerative colitis	0.000639	0.00152	CcSEcCtD
Solifenacin—Tachycardia—Prednisolone—ulcerative colitis	0.000638	0.00152	CcSEcCtD
Solifenacin—Hypertension—Triamcinolone—ulcerative colitis	0.000636	0.00152	CcSEcCtD
Solifenacin—Pruritus—Mesalazine—ulcerative colitis	0.000635	0.00152	CcSEcCtD
Solifenacin—Hypertension—Methylprednisolone—ulcerative colitis	0.000635	0.00152	CcSEcCtD
Solifenacin—Infection—Hydrocortisone—ulcerative colitis	0.000635	0.00151	CcSEcCtD
Solifenacin—Vomiting—Azathioprine—ulcerative colitis	0.000627	0.0015	CcSEcCtD
Solifenacin—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000626	0.0015	CcSEcCtD
Solifenacin—Eye disorder—Prednisone—ulcerative colitis	0.000625	0.00149	CcSEcCtD
Solifenacin—Tachycardia—Hydrocortisone—ulcerative colitis	0.000623	0.00149	CcSEcCtD
Solifenacin—Rash—Azathioprine—ulcerative colitis	0.000622	0.00148	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000622	0.00148	CcSEcCtD
Solifenacin—Dermatitis—Azathioprine—ulcerative colitis	0.000621	0.00148	CcSEcCtD
Solifenacin—Skin disorder—Hydrocortisone—ulcerative colitis	0.00062	0.00148	CcSEcCtD
Solifenacin—Headache—Azathioprine—ulcerative colitis	0.000618	0.00147	CcSEcCtD
Solifenacin—Dry mouth—Triamcinolone—ulcerative colitis	0.000614	0.00146	CcSEcCtD
Solifenacin—Angioedema—Dexamethasone—ulcerative colitis	0.000611	0.00146	CcSEcCtD
Solifenacin—Angioedema—Betamethasone—ulcerative colitis	0.000611	0.00146	CcSEcCtD
Solifenacin—Angiopathy—Prednisone—ulcerative colitis	0.000607	0.00145	CcSEcCtD
Solifenacin—Confusional state—Methylprednisolone—ulcerative colitis	0.000605	0.00144	CcSEcCtD
Solifenacin—Immune system disorder—Prednisone—ulcerative colitis	0.000604	0.00144	CcSEcCtD
Solifenacin—Anaphylactic shock—Triamcinolone—ulcerative colitis	0.000601	0.00144	CcSEcCtD
Solifenacin—Anaphylactic shock—Methylprednisolone—ulcerative colitis	0.0006	0.00143	CcSEcCtD
Solifenacin—Infection—Triamcinolone—ulcerative colitis	0.000597	0.00143	CcSEcCtD
Solifenacin—Infection—Methylprednisolone—ulcerative colitis	0.000596	0.00142	CcSEcCtD
Solifenacin—Dizziness—Mesalazine—ulcerative colitis	0.000594	0.00142	CcSEcCtD
Solifenacin—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000588	0.0014	CcSEcCtD
Solifenacin—Tachycardia—Triamcinolone—ulcerative colitis	0.000587	0.0014	CcSEcCtD
Solifenacin—Mental disorder—Prednisone—ulcerative colitis	0.000586	0.0014	CcSEcCtD
Solifenacin—Nausea—Azathioprine—ulcerative colitis	0.000586	0.0014	CcSEcCtD
Solifenacin—Tachycardia—Methylprednisolone—ulcerative colitis	0.000586	0.0014	CcSEcCtD
Solifenacin—Skin disorder—Methylprednisolone—ulcerative colitis	0.000583	0.00139	CcSEcCtD
Solifenacin—Malnutrition—Prednisone—ulcerative colitis	0.000582	0.00139	CcSEcCtD
Solifenacin—Hypertension—Dexamethasone—ulcerative colitis	0.000577	0.00138	CcSEcCtD
Solifenacin—Hypertension—Betamethasone—ulcerative colitis	0.000577	0.00138	CcSEcCtD
Solifenacin—Vomiting—Mesalazine—ulcerative colitis	0.000571	0.00136	CcSEcCtD
Solifenacin—Rash—Mesalazine—ulcerative colitis	0.000566	0.00135	CcSEcCtD
Solifenacin—Dermatitis—Mesalazine—ulcerative colitis	0.000566	0.00135	CcSEcCtD
Solifenacin—Headache—Mesalazine—ulcerative colitis	0.000563	0.00134	CcSEcCtD
Solifenacin—Dyspepsia—Hydrocortisone—ulcerative colitis	0.000562	0.00134	CcSEcCtD
Solifenacin—Decreased appetite—Hydrocortisone—ulcerative colitis	0.000555	0.00133	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000551	0.00132	CcSEcCtD
Solifenacin—Fatigue—Hydrocortisone—ulcerative colitis	0.000551	0.00131	CcSEcCtD
Solifenacin—Vision blurred—Prednisone—ulcerative colitis	0.000549	0.00131	CcSEcCtD
Solifenacin—Anaphylactic shock—Dexamethasone—ulcerative colitis	0.000546	0.0013	CcSEcCtD
Solifenacin—Anaphylactic shock—Betamethasone—ulcerative colitis	0.000546	0.0013	CcSEcCtD
Solifenacin—Infection—Betamethasone—ulcerative colitis	0.000542	0.00129	CcSEcCtD
Solifenacin—Infection—Dexamethasone—ulcerative colitis	0.000542	0.00129	CcSEcCtD
Solifenacin—Feeling abnormal—Prednisolone—ulcerative colitis	0.000539	0.00129	CcSEcCtD
Solifenacin—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000535	0.00128	CcSEcCtD
Solifenacin—Nervous system disorder—Betamethasone—ulcerative colitis	0.000535	0.00128	CcSEcCtD
Solifenacin—Nausea—Mesalazine—ulcerative colitis	0.000534	0.00127	CcSEcCtD
Solifenacin—Tachycardia—Dexamethasone—ulcerative colitis	0.000533	0.00127	CcSEcCtD
Solifenacin—Tachycardia—Betamethasone—ulcerative colitis	0.000533	0.00127	CcSEcCtD
Solifenacin—Angioedema—Prednisone—ulcerative colitis	0.000532	0.00127	CcSEcCtD
Solifenacin—Dyspepsia—Triamcinolone—ulcerative colitis	0.000529	0.00126	CcSEcCtD
Solifenacin—Dyspepsia—Methylprednisolone—ulcerative colitis	0.000528	0.00126	CcSEcCtD
Solifenacin—Feeling abnormal—Hydrocortisone—ulcerative colitis	0.000526	0.00126	CcSEcCtD
Solifenacin—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000522	0.00125	CcSEcCtD
Solifenacin—Urticaria—Prednisolone—ulcerative colitis	0.00052	0.00124	CcSEcCtD
Solifenacin—Fatigue—Triamcinolone—ulcerative colitis	0.000518	0.00124	CcSEcCtD
Solifenacin—Fatigue—Methylprednisolone—ulcerative colitis	0.000517	0.00124	CcSEcCtD
Solifenacin—Urticaria—Hydrocortisone—ulcerative colitis	0.000507	0.00121	CcSEcCtD
Solifenacin—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000505	0.00121	CcSEcCtD
Solifenacin—Hypertension—Prednisone—ulcerative colitis	0.000503	0.0012	CcSEcCtD
Solifenacin—Feeling abnormal—Triamcinolone—ulcerative colitis	0.000496	0.00118	CcSEcCtD
Solifenacin—Feeling abnormal—Methylprednisolone—ulcerative colitis	0.000494	0.00118	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000492	0.00118	CcSEcCtD
Solifenacin—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000491	0.00117	CcSEcCtD
Solifenacin—Hypersensitivity—Prednisolone—ulcerative colitis	0.000482	0.00115	CcSEcCtD
Solifenacin—Dyspepsia—Betamethasone—ulcerative colitis	0.00048	0.00115	CcSEcCtD
Solifenacin—Dyspepsia—Dexamethasone—ulcerative colitis	0.00048	0.00115	CcSEcCtD
Solifenacin—Urticaria—Triamcinolone—ulcerative colitis	0.000478	0.00114	CcSEcCtD
Solifenacin—Urticaria—Methylprednisolone—ulcerative colitis	0.000477	0.00114	CcSEcCtD
Solifenacin—Anaphylactic shock—Prednisone—ulcerative colitis	0.000475	0.00113	CcSEcCtD
Solifenacin—Abdominal pain—Methylprednisolone—ulcerative colitis	0.000474	0.00113	CcSEcCtD
Solifenacin—Decreased appetite—Betamethasone—ulcerative colitis	0.000474	0.00113	CcSEcCtD
Solifenacin—Decreased appetite—Dexamethasone—ulcerative colitis	0.000474	0.00113	CcSEcCtD
Solifenacin—Infection—Prednisone—ulcerative colitis	0.000472	0.00113	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000471	0.00112	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000471	0.00112	CcSEcCtD
Solifenacin—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.000471	0.00112	CcSEcCtD
Solifenacin—Fatigue—Dexamethasone—ulcerative colitis	0.00047	0.00112	CcSEcCtD
Solifenacin—Fatigue—Betamethasone—ulcerative colitis	0.00047	0.00112	CcSEcCtD
Solifenacin—Nervous system disorder—Prednisone—ulcerative colitis	0.000466	0.00111	CcSEcCtD
Solifenacin—Tachycardia—Prednisone—ulcerative colitis	0.000464	0.00111	CcSEcCtD
Solifenacin—Skin disorder—Prednisone—ulcerative colitis	0.000462	0.0011	CcSEcCtD
Solifenacin—Asthenia—Hydrocortisone—ulcerative colitis	0.000458	0.00109	CcSEcCtD
Solifenacin—Pruritus—Hydrocortisone—ulcerative colitis	0.000452	0.00108	CcSEcCtD
Solifenacin—Feeling abnormal—Dexamethasone—ulcerative colitis	0.00045	0.00107	CcSEcCtD
Solifenacin—Feeling abnormal—Betamethasone—ulcerative colitis	0.00045	0.00107	CcSEcCtD
Solifenacin—Gastrointestinal pain—Betamethasone—ulcerative colitis	0.000446	0.00107	CcSEcCtD
Solifenacin—Gastrointestinal pain—Dexamethasone—ulcerative colitis	0.000446	0.00107	CcSEcCtD
Solifenacin—Hypersensitivity—Triamcinolone—ulcerative colitis	0.000443	0.00106	CcSEcCtD
Solifenacin—Hypersensitivity—Methylprednisolone—ulcerative colitis	0.000442	0.00106	CcSEcCtD
Solifenacin—Urticaria—Betamethasone—ulcerative colitis	0.000433	0.00103	CcSEcCtD
Solifenacin—Urticaria—Dexamethasone—ulcerative colitis	0.000433	0.00103	CcSEcCtD
Solifenacin—Dizziness—Prednisolone—ulcerative colitis	0.000432	0.00103	CcSEcCtD
Solifenacin—Asthenia—Triamcinolone—ulcerative colitis	0.000431	0.00103	CcSEcCtD
Solifenacin—Abdominal pain—Dexamethasone—ulcerative colitis	0.000431	0.00103	CcSEcCtD
Solifenacin—Abdominal pain—Betamethasone—ulcerative colitis	0.000431	0.00103	CcSEcCtD
Solifenacin—Asthenia—Methylprednisolone—ulcerative colitis	0.000431	0.00103	CcSEcCtD
Solifenacin—Pruritus—Triamcinolone—ulcerative colitis	0.000425	0.00102	CcSEcCtD
Solifenacin—Pruritus—Methylprednisolone—ulcerative colitis	0.000425	0.00101	CcSEcCtD
Solifenacin—Dizziness—Hydrocortisone—ulcerative colitis	0.000422	0.00101	CcSEcCtD
Solifenacin—Dyspepsia—Prednisone—ulcerative colitis	0.000418	0.000999	CcSEcCtD
Solifenacin—Decreased appetite—Prednisone—ulcerative colitis	0.000413	0.000986	CcSEcCtD
Solifenacin—Rash—Prednisolone—ulcerative colitis	0.000412	0.000984	CcSEcCtD
Solifenacin—Dermatitis—Prednisolone—ulcerative colitis	0.000412	0.000984	CcSEcCtD
Solifenacin—Fatigue—Prednisone—ulcerative colitis	0.00041	0.000978	CcSEcCtD
Solifenacin—Headache—Prednisolone—ulcerative colitis	0.00041	0.000978	CcSEcCtD
Solifenacin—Constipation—Prednisone—ulcerative colitis	0.000406	0.00097	CcSEcCtD
Solifenacin—Vomiting—Hydrocortisone—ulcerative colitis	0.000406	0.00097	CcSEcCtD
Solifenacin—Rash—Hydrocortisone—ulcerative colitis	0.000403	0.000961	CcSEcCtD
Solifenacin—Dermatitis—Hydrocortisone—ulcerative colitis	0.000402	0.000961	CcSEcCtD
Solifenacin—Headache—Hydrocortisone—ulcerative colitis	0.0004	0.000955	CcSEcCtD
Solifenacin—Dizziness—Triamcinolone—ulcerative colitis	0.000398	0.000949	CcSEcCtD
Solifenacin—Dizziness—Methylprednisolone—ulcerative colitis	0.000397	0.000947	CcSEcCtD
Solifenacin—Feeling abnormal—Prednisone—ulcerative colitis	0.000392	0.000935	CcSEcCtD
Solifenacin—Asthenia—Betamethasone—ulcerative colitis	0.000392	0.000935	CcSEcCtD
Solifenacin—Asthenia—Dexamethasone—ulcerative colitis	0.000392	0.000935	CcSEcCtD
Solifenacin—Gastrointestinal pain—Prednisone—ulcerative colitis	0.000389	0.000928	CcSEcCtD
Solifenacin—Nausea—Prednisolone—ulcerative colitis	0.000388	0.000927	CcSEcCtD
Solifenacin—Pruritus—Betamethasone—ulcerative colitis	0.000386	0.000922	CcSEcCtD
Solifenacin—Pruritus—Dexamethasone—ulcerative colitis	0.000386	0.000922	CcSEcCtD
Solifenacin—Vomiting—Triamcinolone—ulcerative colitis	0.000382	0.000913	CcSEcCtD
Solifenacin—Vomiting—Methylprednisolone—ulcerative colitis	0.000382	0.000911	CcSEcCtD
Solifenacin—Nausea—Hydrocortisone—ulcerative colitis	0.000379	0.000906	CcSEcCtD
Solifenacin—Rash—Triamcinolone—ulcerative colitis	0.000379	0.000905	CcSEcCtD
Solifenacin—Dermatitis—Triamcinolone—ulcerative colitis	0.000379	0.000904	CcSEcCtD
Solifenacin—Rash—Methylprednisolone—ulcerative colitis	0.000378	0.000903	CcSEcCtD
Solifenacin—Dermatitis—Methylprednisolone—ulcerative colitis	0.000378	0.000902	CcSEcCtD
Solifenacin—Urticaria—Prednisone—ulcerative colitis	0.000378	0.000901	CcSEcCtD
Solifenacin—Headache—Triamcinolone—ulcerative colitis	0.000377	0.000899	CcSEcCtD
Solifenacin—Headache—Methylprednisolone—ulcerative colitis	0.000376	0.000897	CcSEcCtD
Solifenacin—Abdominal pain—Prednisone—ulcerative colitis	0.000376	0.000897	CcSEcCtD
Solifenacin—Dizziness—Dexamethasone—ulcerative colitis	0.000361	0.000861	CcSEcCtD
Solifenacin—Dizziness—Betamethasone—ulcerative colitis	0.000361	0.000861	CcSEcCtD
Solifenacin—Nausea—Triamcinolone—ulcerative colitis	0.000357	0.000853	CcSEcCtD
Solifenacin—Nausea—Methylprednisolone—ulcerative colitis	0.000356	0.000851	CcSEcCtD
Solifenacin—Hypersensitivity—Prednisone—ulcerative colitis	0.00035	0.000836	CcSEcCtD
Solifenacin—Vomiting—Dexamethasone—ulcerative colitis	0.000347	0.000828	CcSEcCtD
Solifenacin—Vomiting—Betamethasone—ulcerative colitis	0.000347	0.000828	CcSEcCtD
Solifenacin—Rash—Dexamethasone—ulcerative colitis	0.000344	0.000821	CcSEcCtD
Solifenacin—Rash—Betamethasone—ulcerative colitis	0.000344	0.000821	CcSEcCtD
Solifenacin—Dermatitis—Dexamethasone—ulcerative colitis	0.000344	0.000821	CcSEcCtD
Solifenacin—Dermatitis—Betamethasone—ulcerative colitis	0.000344	0.000821	CcSEcCtD
Solifenacin—Headache—Betamethasone—ulcerative colitis	0.000342	0.000816	CcSEcCtD
Solifenacin—Headache—Dexamethasone—ulcerative colitis	0.000342	0.000816	CcSEcCtD
Solifenacin—Asthenia—Prednisone—ulcerative colitis	0.000341	0.000814	CcSEcCtD
Solifenacin—Pruritus—Prednisone—ulcerative colitis	0.000336	0.000803	CcSEcCtD
Solifenacin—Nausea—Dexamethasone—ulcerative colitis	0.000324	0.000774	CcSEcCtD
Solifenacin—Nausea—Betamethasone—ulcerative colitis	0.000324	0.000774	CcSEcCtD
Solifenacin—Dizziness—Prednisone—ulcerative colitis	0.000314	0.00075	CcSEcCtD
Solifenacin—Vomiting—Prednisone—ulcerative colitis	0.000302	0.000721	CcSEcCtD
Solifenacin—Rash—Prednisone—ulcerative colitis	0.0003	0.000715	CcSEcCtD
Solifenacin—Dermatitis—Prednisone—ulcerative colitis	0.000299	0.000715	CcSEcCtD
Solifenacin—Headache—Prednisone—ulcerative colitis	0.000298	0.000711	CcSEcCtD
Solifenacin—Nausea—Prednisone—ulcerative colitis	0.000282	0.000674	CcSEcCtD
Solifenacin—CHRM3—GPCR ligand binding—ADRB2—ulcerative colitis	9.65e-05	0.00139	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—ADRB2—ulcerative colitis	9.56e-05	0.00138	CbGpPWpGaD
Solifenacin—CHRM2—SIDS Susceptibility Pathways—NFKB1—ulcerative colitis	9.47e-05	0.00136	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—DLD—ulcerative colitis	9.41e-05	0.00136	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—GHRL—ulcerative colitis	9.39e-05	0.00135	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—PTGER4—ulcerative colitis	9.31e-05	0.00134	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—GNA12—ulcerative colitis	9.2e-05	0.00133	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—GNA12—ulcerative colitis	9.17e-05	0.00132	CbGpPWpGaD
Solifenacin—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	9.11e-05	0.00131	CbGpPWpGaD
Solifenacin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	9.09e-05	0.00131	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—GNA12—ulcerative colitis	9.09e-05	0.00131	CbGpPWpGaD
Solifenacin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	9.06e-05	0.00131	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—GHRL—ulcerative colitis	8.91e-05	0.00128	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—CCL20—ulcerative colitis	8.89e-05	0.00128	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CXCR1—ulcerative colitis	8.87e-05	0.00128	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—CCL20—ulcerative colitis	8.86e-05	0.00128	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—CCL20—ulcerative colitis	8.78e-05	0.00126	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—CXCR2—ulcerative colitis	8.73e-05	0.00126	CbGpPWpGaD
Solifenacin—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	8.72e-05	0.00126	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—CXCR2—ulcerative colitis	8.7e-05	0.00125	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—CALM3—ulcerative colitis	8.62e-05	0.00124	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—CXCR2—ulcerative colitis	8.61e-05	0.00124	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—GHRL—ulcerative colitis	8.53e-05	0.00123	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CXCR1—ulcerative colitis	8.5e-05	0.00122	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—GNA12—ulcerative colitis	8.36e-05	0.0012	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—GNA12—ulcerative colitis	8.33e-05	0.0012	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—CALM3—ulcerative colitis	8.26e-05	0.00119	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—GNA12—ulcerative colitis	8.25e-05	0.00119	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—CCR6—ulcerative colitis	8.2e-05	0.00118	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—CCR6—ulcerative colitis	8.18e-05	0.00118	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—ADRB2—ulcerative colitis	8.12e-05	0.00117	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—CCR6—ulcerative colitis	8.1e-05	0.00117	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—CXCR2—ulcerative colitis	7.92e-05	0.00114	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—CXCR2—ulcerative colitis	7.9e-05	0.00114	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—CXCR2—ulcerative colitis	7.82e-05	0.00113	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CCL20—ulcerative colitis	7.79e-05	0.00112	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—ADRB2—ulcerative colitis	7.77e-05	0.00112	CbGpPWpGaD
Solifenacin—CHRM2—G alpha (i) signalling events—CXCL8—ulcerative colitis	7.63e-05	0.0011	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CCL20—ulcerative colitis	7.46e-05	0.00107	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—CCR6—ulcerative colitis	7.45e-05	0.00107	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—CCR6—ulcerative colitis	7.43e-05	0.00107	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—ADRB2—ulcerative colitis	7.37e-05	0.00106	CbGpPWpGaD
Solifenacin—CHRM2—SIDS Susceptibility Pathways—TNF—ulcerative colitis	7.37e-05	0.00106	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—CCR6—ulcerative colitis	7.35e-05	0.00106	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—GNA12—ulcerative colitis	7.32e-05	0.00105	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—SEL1L—ulcerative colitis	7.26e-05	0.00105	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—SEL1L—ulcerative colitis	7.24e-05	0.00104	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—PTGER4—ulcerative colitis	7.22e-05	0.00104	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—PTGER4—ulcerative colitis	7.2e-05	0.00104	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—SEL1L—ulcerative colitis	7.17e-05	0.00103	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—PTGER4—ulcerative colitis	7.13e-05	0.00103	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—ADRB2—ulcerative colitis	7.06e-05	0.00102	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—GNA12—ulcerative colitis	7.01e-05	0.00101	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CXCR2—ulcerative colitis	6.94e-05	0.001	CbGpPWpGaD
Solifenacin—CHRM4—GPCR ligand binding—CXCL8—ulcerative colitis	6.94e-05	0.000999	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—ADCY5—ulcerative colitis	6.89e-05	0.000992	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CXCR2—ulcerative colitis	6.65e-05	0.000958	CbGpPWpGaD
Solifenacin—CHRM5—GPCR ligand binding—CXCL8—ulcerative colitis	6.64e-05	0.000957	CbGpPWpGaD
Solifenacin—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	6.62e-05	0.000953	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—GHRL—ulcerative colitis	6.61e-05	0.000952	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—ADCY5—ulcerative colitis	6.6e-05	0.00095	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—GHRL—ulcerative colitis	6.59e-05	0.000949	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—PTGER4—ulcerative colitis	6.56e-05	0.000945	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—PTGER4—ulcerative colitis	6.54e-05	0.000942	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—GHRL—ulcerative colitis	6.53e-05	0.00094	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CCR6—ulcerative colitis	6.53e-05	0.00094	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—PTGER4—ulcerative colitis	6.47e-05	0.000933	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—ADCY5—ulcerative colitis	6.26e-05	0.000901	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CCR6—ulcerative colitis	6.25e-05	0.0009	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—MAML2—ulcerative colitis	6.19e-05	0.000891	CbGpPWpGaD
Solifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	6.14e-05	0.000885	CbGpPWpGaD
Solifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	6.12e-05	0.000882	CbGpPWpGaD
Solifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	6.06e-05	0.000873	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—GHRL—ulcerative colitis	6e-05	0.000865	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—ADCY5—ulcerative colitis	5.99e-05	0.000863	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—GHRL—ulcerative colitis	5.99e-05	0.000862	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CXCR1—ulcerative colitis	5.98e-05	0.000862	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CXCR1—ulcerative colitis	5.96e-05	0.000859	CbGpPWpGaD
Solifenacin—CHRM2—SIDS Susceptibility Pathways—IL6—ulcerative colitis	5.95e-05	0.000856	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—GHRL—ulcerative colitis	5.93e-05	0.000854	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—MAML2—ulcerative colitis	5.92e-05	0.000853	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CXCR1—ulcerative colitis	5.9e-05	0.00085	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—CALM3—ulcerative colitis	5.82e-05	0.000838	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—CALM3—ulcerative colitis	5.8e-05	0.000835	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—PTGER4—ulcerative colitis	5.75e-05	0.000828	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—CALM3—ulcerative colitis	5.74e-05	0.000827	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—PTGER4—ulcerative colitis	5.5e-05	0.000793	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—ADRB2—ulcerative colitis	5.47e-05	0.000788	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—ADRB2—ulcerative colitis	5.46e-05	0.000786	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—ADRB2—ulcerative colitis	5.4e-05	0.000778	CbGpPWpGaD
Solifenacin—CHRM1—Circadian rythm related genes—TP53—ulcerative colitis	5.37e-05	0.000774	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—GHRL—ulcerative colitis	5.26e-05	0.000758	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CCL20—ulcerative colitis	5.25e-05	0.000756	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CCL20—ulcerative colitis	5.23e-05	0.000754	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CCL20—ulcerative colitis	5.18e-05	0.000747	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CALM3—ulcerative colitis	5.09e-05	0.000734	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—GHRL—ulcerative colitis	5.04e-05	0.000726	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—RIPK2—ulcerative colitis	5.02e-05	0.000723	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—ADRB2—ulcerative colitis	4.97e-05	0.000716	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—ADRB2—ulcerative colitis	4.95e-05	0.000714	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—GNA12—ulcerative colitis	4.94e-05	0.000711	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—GNA12—ulcerative colitis	4.92e-05	0.000709	CbGpPWpGaD
Solifenacin—CHRM1—Circadian rythm related genes—IL6—ulcerative colitis	4.92e-05	0.000708	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—ADRB2—ulcerative colitis	4.91e-05	0.000707	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CALM3—ulcerative colitis	4.88e-05	0.000703	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—GNA12—ulcerative colitis	4.87e-05	0.000702	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—RIPK2—ulcerative colitis	4.81e-05	0.000692	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CXCR2—ulcerative colitis	4.68e-05	0.000674	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—CXCL8—ulcerative colitis	4.68e-05	0.000674	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CXCR2—ulcerative colitis	4.67e-05	0.000672	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—CXCL8—ulcerative colitis	4.66e-05	0.000672	CbGpPWpGaD
Solifenacin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	4.66e-05	0.000671	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—ADCY5—ulcerative colitis	4.65e-05	0.000669	CbGpPWpGaD
Solifenacin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	4.65e-05	0.000669	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—ADCY5—ulcerative colitis	4.63e-05	0.000667	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CXCR2—ulcerative colitis	4.62e-05	0.000666	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—CXCL8—ulcerative colitis	4.62e-05	0.000665	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—ADCY5—ulcerative colitis	4.59e-05	0.000661	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PTGS1—ulcerative colitis	4.55e-05	0.000655	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CCR6—ulcerative colitis	4.4e-05	0.000634	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CCR6—ulcerative colitis	4.39e-05	0.000632	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—ADRB2—ulcerative colitis	4.35e-05	0.000627	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CCR6—ulcerative colitis	4.34e-05	0.000626	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—JAK2—ulcerative colitis	4.3e-05	0.000619	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CHP1—ulcerative colitis	4.26e-05	0.000614	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—ADCY5—ulcerative colitis	4.22e-05	0.000608	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—ADCY5—ulcerative colitis	4.21e-05	0.000606	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MAML2—ulcerative colitis	4.17e-05	0.000601	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—ADRB2—ulcerative colitis	4.17e-05	0.000601	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—ADCY5—ulcerative colitis	4.16e-05	0.0006	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MAML2—ulcerative colitis	4.16e-05	0.000599	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MAML2—ulcerative colitis	4.12e-05	0.000593	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—JAK2—ulcerative colitis	4.11e-05	0.000593	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—CALM3—ulcerative colitis	4.1e-05	0.00059	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—CXCL8—ulcerative colitis	3.92e-05	0.000565	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—JAK2—ulcerative colitis	3.9e-05	0.000562	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PTGER4—ulcerative colitis	3.87e-05	0.000558	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PTGER4—ulcerative colitis	3.86e-05	0.000556	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PTGER4—ulcerative colitis	3.82e-05	0.000551	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—CXCL8—ulcerative colitis	3.75e-05	0.000541	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—IL2—ulcerative colitis	3.75e-05	0.00054	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—JAK2—ulcerative colitis	3.74e-05	0.000538	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—ADCY5—ulcerative colitis	3.7e-05	0.000532	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—DLD—ulcerative colitis	3.68e-05	0.00053	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—IL2—ulcerative colitis	3.59e-05	0.000517	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—CXCL8—ulcerative colitis	3.56e-05	0.000513	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—GHRL—ulcerative colitis	3.55e-05	0.000511	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—ADCY5—ulcerative colitis	3.54e-05	0.00051	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—GHRL—ulcerative colitis	3.54e-05	0.000509	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—GHRL—ulcerative colitis	3.5e-05	0.000504	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CALM3—ulcerative colitis	3.44e-05	0.000495	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CALM3—ulcerative colitis	3.42e-05	0.000493	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—CXCL8—ulcerative colitis	3.41e-05	0.000491	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—IL2—ulcerative colitis	3.4e-05	0.00049	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CALM3—ulcerative colitis	3.39e-05	0.000488	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—RIPK2—ulcerative colitis	3.38e-05	0.000487	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—RIPK2—ulcerative colitis	3.37e-05	0.000486	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—RIPK2—ulcerative colitis	3.34e-05	0.000481	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—IL2—ulcerative colitis	3.26e-05	0.000469	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—ABCB1—ulcerative colitis	3.18e-05	0.000459	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—ADCY5—ulcerative colitis	2.97e-05	0.000428	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—ADRB2—ulcerative colitis	2.94e-05	0.000423	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—ADRB2—ulcerative colitis	2.93e-05	0.000422	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—ADRB2—ulcerative colitis	2.9e-05	0.000417	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—JAK2—ulcerative colitis	2.9e-05	0.000417	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—JAK2—ulcerative colitis	2.89e-05	0.000416	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—JAK2—ulcerative colitis	2.86e-05	0.000412	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—CXCL8—ulcerative colitis	2.64e-05	0.000381	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—CXCL8—ulcerative colitis	2.64e-05	0.00038	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—JAK2—ulcerative colitis	2.63e-05	0.000379	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—JAK2—ulcerative colitis	2.62e-05	0.000378	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—CXCL8—ulcerative colitis	2.61e-05	0.000376	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—JAK2—ulcerative colitis	2.6e-05	0.000374	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—IL2—ulcerative colitis	2.53e-05	0.000364	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—IL2—ulcerative colitis	2.52e-05	0.000363	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—IL2—ulcerative colitis	2.49e-05	0.000359	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—ADCY5—ulcerative colitis	2.49e-05	0.000359	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—ADCY5—ulcerative colitis	2.48e-05	0.000358	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—ADCY5—ulcerative colitis	2.46e-05	0.000354	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—CXCL8—ulcerative colitis	2.4e-05	0.000346	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—CXCL8—ulcerative colitis	2.39e-05	0.000345	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—CXCL8—ulcerative colitis	2.37e-05	0.000341	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—JAK2—ulcerative colitis	2.3e-05	0.000332	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—IL2—ulcerative colitis	2.29e-05	0.00033	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—IL2—ulcerative colitis	2.29e-05	0.000329	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—IL2—ulcerative colitis	2.26e-05	0.000326	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—RELA—ulcerative colitis	2.23e-05	0.000321	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PPARG—ulcerative colitis	2.22e-05	0.000319	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—JAK2—ulcerative colitis	2.21e-05	0.000318	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—RELA—ulcerative colitis	2.14e-05	0.000308	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CXCL8—ulcerative colitis	2.1e-05	0.000303	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CXCL8—ulcerative colitis	2.01e-05	0.00029	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—IL2—ulcerative colitis	2.01e-05	0.00029	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—IL6—ulcerative colitis	2e-05	0.000288	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—ALB—ulcerative colitis	1.99e-05	0.000287	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—IL2—ulcerative colitis	1.92e-05	0.000277	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—IL6—ulcerative colitis	1.92e-05	0.000276	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—MMP9—ulcerative colitis	1.9e-05	0.000274	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—NFKB1—ulcerative colitis	1.88e-05	0.000271	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—MMP9—ulcerative colitis	1.82e-05	0.000262	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—NFKB1—ulcerative colitis	1.8e-05	0.00026	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PTGS1—ulcerative colitis	1.78e-05	0.000256	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PTGS2—ulcerative colitis	1.74e-05	0.000251	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—STAT3—ulcerative colitis	1.69e-05	0.000244	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—STAT3—ulcerative colitis	1.62e-05	0.000233	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CALM3—ulcerative colitis	1.6e-05	0.000231	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—TGFB1—ulcerative colitis	1.57e-05	0.000226	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—JAK2—ulcerative colitis	1.55e-05	0.000224	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—JAK2—ulcerative colitis	1.55e-05	0.000223	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—JAK2—ulcerative colitis	1.53e-05	0.000221	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—RELA—ulcerative colitis	1.5e-05	0.000217	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—TGFB1—ulcerative colitis	1.5e-05	0.000216	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—RELA—ulcerative colitis	1.5e-05	0.000216	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—RELA—ulcerative colitis	1.49e-05	0.000214	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CXCL8—ulcerative colitis	1.42e-05	0.000204	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CXCL8—ulcerative colitis	1.41e-05	0.000204	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CXCL8—ulcerative colitis	1.4e-05	0.000202	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IL2—ulcerative colitis	1.36e-05	0.000195	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IL2—ulcerative colitis	1.35e-05	0.000195	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—IL6—ulcerative colitis	1.35e-05	0.000194	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—IL6—ulcerative colitis	1.34e-05	0.000194	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IL2—ulcerative colitis	1.34e-05	0.000193	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—IL6—ulcerative colitis	1.33e-05	0.000192	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—TP53—ulcerative colitis	1.29e-05	0.000186	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MMP9—ulcerative colitis	1.28e-05	0.000185	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MMP9—ulcerative colitis	1.28e-05	0.000184	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—NFKB1—ulcerative colitis	1.27e-05	0.000183	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MMP9—ulcerative colitis	1.27e-05	0.000182	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—NFKB1—ulcerative colitis	1.26e-05	0.000182	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—NFKB1—ulcerative colitis	1.25e-05	0.00018	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ABCB1—ulcerative colitis	1.25e-05	0.000179	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—TP53—ulcerative colitis	1.24e-05	0.000178	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—IL6—ulcerative colitis	1.18e-05	0.00017	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ADCY5—ulcerative colitis	1.16e-05	0.000167	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—STAT3—ulcerative colitis	1.14e-05	0.000164	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—STAT3—ulcerative colitis	1.14e-05	0.000164	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—IL6—ulcerative colitis	1.13e-05	0.000163	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—STAT3—ulcerative colitis	1.13e-05	0.000162	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—TGFB1—ulcerative colitis	1.06e-05	0.000152	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—TGFB1—ulcerative colitis	1.05e-05	0.000152	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—TGFB1—ulcerative colitis	1.04e-05	0.00015	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—TP53—ulcerative colitis	8.7e-06	0.000125	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—TP53—ulcerative colitis	8.67e-06	0.000125	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PPARG—ulcerative colitis	8.66e-06	0.000125	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—TP53—ulcerative colitis	8.59e-06	0.000124	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IL6—ulcerative colitis	7.97e-06	0.000115	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IL6—ulcerative colitis	7.94e-06	0.000114	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IL6—ulcerative colitis	7.86e-06	0.000113	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ALB—ulcerative colitis	7.79e-06	0.000112	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PTGS2—ulcerative colitis	6.81e-06	9.82e-05	CbGpPWpGaD
